Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00091026
Status:
COMPLETED
Last Update Posted:
2014-05-15
First Post:
2004-09-07
Brief Title:
Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Pancreatic Cancer |
| Adenocarcinoma of the Pancreas |
| Recurrent Pancreatic Cancer |
| Stage II Pancreatic Cancer |
| Stage III Pancreatic Cancer |
Keywords: